综合应用临床影像学对乳腺癌进行筛查、诊断和分期

赵晋华; 郭慧敏

doi:10.3760/cma.j.issn.1673-4114.2009.04.009

赵晋华 , 郭慧敏

文章导航 > 国际放射医学核医学杂志 > 2009, 33 > 4: (222-225)

引用本文:

Citation:

综合应用临床影像学对乳腺癌进行筛查、诊断和分期

赵晋华^,,
郭慧敏

上海交通大学附属第一人民医院核医学科, 上海, 200080

通讯作者: 赵晋华, zjh1963@gmail.com ;

The combination of clinical imaging methods in the screening, diagnosis and staging of patients with breast cancer

ZHAO Jin-hua^,,
GUO Hui-min

Department of Nuclear Medicine, the First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China

Corresponding author: ZHAO Jin-hua, zjh1963@gmail.com ;

摘要: 乳腺癌是导致女性因癌症而死亡的主要原因。尽管乳腺癌的发病率在增加,但随着诊断和治疗技术的进步,其病死率下降。影像学方法在检测乳腺癌、指导治疗方面起着关键作用。尤其是放射性核素显像在乳腺癌的诊断和分期方面发挥了重要的作用。
- 乳腺肿瘤 /
- 体层摄影术,X线计算机 /
- 超声检查 /
- 磁共振成像 /
- 体层摄影术,发射型计算机
Abstract: Breast cancer is one major reason for leading cause of cancer mortality in women.Advances in diagnosis and treatment have led to declines in mortality, despite an increase in breast cancer incidence. Imaging plays a key role in detecting breast cancer and directing its therapy. Especially,radionuclide imaging for detection and staging of breast cancer make a significant impact.
- Breast neoplasms /
- Tomography,X-ray computed /
- Ultrasonography /
- Magetic resonance imaging /
- Tomography,emission-computed
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2007.CA Caner J Clin, 2007, 57(1):43-66.
[2]	Lee JH, Rosen EL, Mankoff DA.The role of radiotracer imaging in the diagnosis and management of patients with breast cancer:part1-overview, detection, and staging.J Nucl Med, 2009, 50(4):569-581.
[3]	赵亚平, 周世英, 刘荣波.等.乳腺X线片中成簇样微小钙化对乳腺癌的诊断价值.临床放射学杂志, 2001, 20(1):7-10.
[4]	汪敏, 彭绩, 许奕华, 等.超声检查、乳房X线摄影术在乳腺癌筛查和早期诊断中作用的Meta分析.疾病控制杂志, 2006, 10(1):33-34.
[5]	Abe N, Schmidt RA, Sennett CA, et al.US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer:why and how to do it.Radiographics, 2007, 27(suppl 1):S91-S99.
[6]	陈林丽, 赵建农, 郭大静, 等.1H-MRS联合DCE-MRI在乳腺痛中的应用价值.中国医学计算机成像杂志, 2008, 14(2):106-110.
[7]	Mankoff DA, Dunnwald LK, Gralow JR, et al.[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.Nucl Med Biol, 2002, 29(7):719-727.
[8]	Liberman M, Sampalis F, Mulder DS, et al.Breast cancer diagnosis by scintimammography:a meta-analysis and review of the literature.Breast Cancer Res Treat, 2003, 80(1):115-126.
[9]	Brem RF, Fishman M, Rapelyea JA.Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging, a comparative study.Acad Radiol,2007, 14(8):945-950.
[10]	Brem RF, Floerkc AC, Rapelyea JA, et al.Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.Radiology, 2008, 247(3):651-657.
[11]	Longer I, Guller U, Berclaz G, et al.Mobidity of sentinel lymphnode biopsy (SLN) alone versus SLN and completion axillary lymph node dessection after breast cancer surgery:a prospective Swiss multicenter study on 659 patients.Ann Surg, 2007, 245(3):452-461.
[12]	李囡, 林保和, 欧阳涛, 等.467例乳腺癌患者⁹⁹Tc^m-利妥昔单抗前哨淋巴结显像结果分析.中华核医学杂志, 2009, 29(1):3-7.
[13]	周敏, 章英剑, 程竞仪.内乳前哨淋巴结⁹⁹Tc^m-硫胶体显像影响因素分析.中华核医学杂志, 2009, 29(1):8-11.
[14]	Kumar R, Chauhan A, Zhuang H, et al.Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.Breast Cancer Res Treat, 2006, 98(3):267-274.
[15]	Rosen EL, Eubank WB, Mankoff DA.FDG PET, PET/CT, and breast cancer imaging.Radiographics, 2007, 27(suppl 1):S215-S229.
[16]	Raylman RR, Majewski S, Smith MF, et al.The positron emission mammography/tomography breast imaging and biopsy system(PEM/PET):design, construction and phantom-based measurem-ents.Phys Med Biol, 2008, 53(3):637-653.
[17]	Wahl RL, Siegel BA, Coleman RE, et al.Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:a report of the staging breast cancer with PET study group.J Clin Oncl, 2004, 22(2):277-285.
[18]	Grant FD, Fahey FH, Packard AB, et al.Skeletal PET with ¹⁸F-fluoride:applying new technology to an old traccr.J Nucl Med,2008, 49(1):68-78.
[19]	Fogelman I, Cook G, Isreal O, et al.Positron emission tomography and bone metastases.Semin Nucl Med, 2005, 35(2):135-142.

[1]	郭慧敏 , 赵晋华 . 应用影像学方法评价乳腺癌新辅助化疗疗效. 国际放射医学核医学杂志, 2009, 33(3): 149-153. doi: 10.3760/cma.j.issn.1673-4114.2009.03.006
[2]	隗功华 , 孙晓光 . 医学影像学在肿瘤治疗疗效评价中的应用. 国际放射医学核医学杂志, 2009, 33(1): 43-46. doi: 10.3760/cma.j.issn.1673-4114.2009.01.043
[3]	董佳佳 , 章斌 . 多种影像学方法评价乳腺癌新辅助化疗疗效的价值比较. 国际放射医学核医学杂志, 2014, 38(6): 427-432. doi: 10.3760/cma.j.issn.1673-4114.2014.06.018
[4]	夏晓天 , 张永学 . 影像学检查在乳腺癌的诊断及疗效评估中的应用价值. 国际放射医学核医学杂志, 2010, 34(4): 242-246, 249. doi: 10.3760/cma.j.issn.1673-4114.2010.04.014
[5]	刘晓瑜 , 林翠君 , 黄洁 , 代海洋 . 不同分子分型乳腺癌的超声、MRI及乳腺X射线摄影特征的诊断价值. 国际放射医学核医学杂志, 2024, 48(2): 74-81. doi: 10.3760/cma.j.cn121381-202212013-00349
[6]	冯学民 . 甲状腺癌的影像学研究进展. 国际放射医学核医学杂志, 2006, 30(5): 275-280.
[7]	董华 , 张遵城 . 眼眶海绵状血管瘤的影像学分析. 国际放射医学核医学杂志, 2008, 32(1): 55-57,62.
[8]	卢晓莉 , 张俊 , 王峰 , 王自正 . 影像学技术对转移性淋巴结的诊断价值. 国际放射医学核医学杂志, 2011, 35(6): 334-338. doi: 10.3760,cma.j.issn.1673-4114.2011.06.004
[9]	李万婷 , 刘海燕 , 秦丽军 , 崔雅丽 , 牛静 , 武志芳 , 刘静 , 张国琛 , 任媛 , 李思进 . ⁹⁹Tc^m-3PRGD₂整合素受体显像鉴别乳腺良恶性病变的价值及与超声检查的对比研究. 国际放射医学核医学杂志, 2018, 42(3): 242-247. doi: 10.3760/cma.j.issn.1673-4114.2018.03.009
[10]	余丰文 , 冯彦林 , 贺小红 , 刘德军 , 温广华 , 袁建伟 . PET-CT与钼靶X线、B超定性诊断乳腺癌的临床对比研究. 国际放射医学核医学杂志, 2006, 30(3): 148-151.
[11]	陈贵兵 , 欧阳忠 , 韩成坤 , 黄劲雄 , 何小江 , 王凡 , 贾兵 , 吴华 . ⁹⁹Tc^m-3PRGD2整合素受体显像在乳腺癌定性诊断中的价值及与钼靶检查的对比研究. 国际放射医学核医学杂志, 2017, 41(1): 1-7. doi: 10.3760/cma.j.issn.1673-4114.2017.01.001